Pleasanton, CA – According to filings with the U.S. Securities and Exchange Commission, Sandstone Diagnostics is raising $4,000,000.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Karen Drexler played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Sandstone Diagnostics

Sandstone Diagnostics is a Bay Area consumer health company focused on innovative technologies that empower people to measure and improve important health markers at home.  Sandstone’s lead product, Trak, is a home test kit and mobile app that allows men to measure, track, and try to improve their sperm count at home as couples are trying to conceive. Trak is a tool for men to take charge of their fertility and improve their chances of conception. To learn more about Sandstone Diagnostics, visit http://trakfertility.com/

Contact:
Karen Drexler, Chief Executive Officer
925-447-4660
karen@trakfertility.com
https://www.linkedin.com/in/karendrexler/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved